Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2014

Open Access 01-12-2014 | Research article

Possible extracardiac predictors of aortic dissection in Marfan syndrome

Authors: Bence Ágg, Kálmán Benke, Bálint Szilveszter, Miklós Pólos, László Daróczi, Balázs Odler, Zsolt B Nagy, Ferenc Tarr, Béla Merkely, Zoltán Szabolcs

Published in: BMC Cardiovascular Disorders | Issue 1/2014

Login to get access

Abstract

Background

According to previous studies, aortic diameter alone seems to be insufficient to predict the event of aortic dissection in Marfan syndrome (MFS). Determining the optimal schedule for preventive aortic root replacement (ARR) aortic growth rate is of importance, as well as family history, however, none of them appear to be decisive. Thus, the aim of this study was to search for potential predictors of aortic dissection in MFS.

Methods

A Marfan Biobank consisting of 79 MFS patients was established. Thirty-nine MFS patients who underwent ARR were assigned into three groups based on the indication for surgery (dissection, annuloaortic ectasia and prophylactic surgery). The prophylactic surgery group was excluded from the study. Transforming growth factor-β (TGF-β) serum levels were measured by ELISA, relative expression of c-Fos, matrix metalloproteinase 3 and 9 (MMP-3 and −9) were assessed by RT-PCR. Clinical parameters, including anthropometric variables - based on the original Ghent criteria were also analyzed.

Results

Among patients with aortic dissection, TGF-β serum level was elevated (43.78 ± 6.51 vs. 31.64 ± 4.99 ng/l, p < 0.0001), MMP-3 was up-regulated (Ln2α = 1.87, p = 0.062) and striae atrophicae were more common (92% vs. 41% p = 0.027) compared to the annuloaortic ectasia group.

Conclusions

We found three easily measurable parameters (striae atrophicae, TGF-β serum level, MMP-3) that may help to predict the risk of aortic dissection in MFS. Based on these findings a new classification of MFS, that is benign or malignant is also proposed, which could be taken into consideration in determining the timing of prophylactic ARR.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gao LG, Luo F, Hui RT, Zhou XL: Recent molecular biological progress in Marfan syndrome and Marfan-associated disorders. Ageing Res Rev. 2010, 9 (3): 363-368. 10.1016/j.arr.2009.09.001.CrossRefPubMed Gao LG, Luo F, Hui RT, Zhou XL: Recent molecular biological progress in Marfan syndrome and Marfan-associated disorders. Ageing Res Rev. 2010, 9 (3): 363-368. 10.1016/j.arr.2009.09.001.CrossRefPubMed
2.
go back to reference Colovati ME, da Silva LR, Takeno SS, Mancini TI, N Dutra AR, Guilherme RS, de Mello CB, Melaragno MI, A Perez AB: Marfan syndrome with a complex chromosomal rearrangement including deletion of the FBN1 gene. Mol Cytogenet. 2012, 5: 5-10.1186/1755-8166-5-5.CrossRefPubMedPubMedCentral Colovati ME, da Silva LR, Takeno SS, Mancini TI, N Dutra AR, Guilherme RS, de Mello CB, Melaragno MI, A Perez AB: Marfan syndrome with a complex chromosomal rearrangement including deletion of the FBN1 gene. Mol Cytogenet. 2012, 5: 5-10.1186/1755-8166-5-5.CrossRefPubMedPubMedCentral
3.
go back to reference Holm TM, Habashi JP, Doyle JJ, Bedja D, Chen Y, van Erp C, Lindsay ME, Kim D, Schoenhoff F, Cohn RD, Loeys BL, Thomas CJ, Patnaik S, Marugan JJ, Judge DP, Dietz HC: Noncanonical TGFβ signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science. 2011, 332 (6027): 358-361. 10.1126/science.1192149.CrossRefPubMedPubMedCentral Holm TM, Habashi JP, Doyle JJ, Bedja D, Chen Y, van Erp C, Lindsay ME, Kim D, Schoenhoff F, Cohn RD, Loeys BL, Thomas CJ, Patnaik S, Marugan JJ, Judge DP, Dietz HC: Noncanonical TGFβ signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science. 2011, 332 (6027): 358-361. 10.1126/science.1192149.CrossRefPubMedPubMedCentral
4.
go back to reference Chung AW, Yang HH, Radomski MW, van Breemen C: Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and −9. Circ Res. 2008, 102 (8): e73-e85. 10.1161/CIRCRESAHA.108.174367.CrossRefPubMed Chung AW, Yang HH, Radomski MW, van Breemen C: Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and −9. Circ Res. 2008, 102 (8): e73-e85. 10.1161/CIRCRESAHA.108.174367.CrossRefPubMed
5.
go back to reference Ahimastos AA, Aggarwal A, Savarirayan R, Dart AM, Kingwell BA: A role for plasma transforming growth factor-beta and matrix metalloproteinases in aortic aneurysm surveillance in Marfan syndrome?. Atherosclerosis. 2010, 209 (1): 211-214. 10.1016/j.atherosclerosis.2009.08.003.CrossRefPubMed Ahimastos AA, Aggarwal A, Savarirayan R, Dart AM, Kingwell BA: A role for plasma transforming growth factor-beta and matrix metalloproteinases in aortic aneurysm surveillance in Marfan syndrome?. Atherosclerosis. 2010, 209 (1): 211-214. 10.1016/j.atherosclerosis.2009.08.003.CrossRefPubMed
6.
go back to reference Benke K, Ágg B, Szilveszter B, Tarr F, Nagy ZB, Pólos M, Daróczi L, Merkely B, Szabolcs Z: The role of TGF-β in Marfan syndrome. Cardiol J. 2013, 20 (3): 227-234. 10.5603/CJ.2013.0066.CrossRefPubMed Benke K, Ágg B, Szilveszter B, Tarr F, Nagy ZB, Pólos M, Daróczi L, Merkely B, Szabolcs Z: The role of TGF-β in Marfan syndrome. Cardiol J. 2013, 20 (3): 227-234. 10.5603/CJ.2013.0066.CrossRefPubMed
7.
go back to reference Neri E, Barabesi L, Buklas D, Vricella LA, Benvenuti A, Tucci E, Sassi C, Masseti M: Limited role of aortic size in the genesis of acute type A aortic dissection. Eur J Cardiothorac Surg. 2005, 28 (6): 857-863. 10.1016/j.ejcts.2005.10.013.CrossRefPubMed Neri E, Barabesi L, Buklas D, Vricella LA, Benvenuti A, Tucci E, Sassi C, Masseti M: Limited role of aortic size in the genesis of acute type A aortic dissection. Eur J Cardiothorac Surg. 2005, 28 (6): 857-863. 10.1016/j.ejcts.2005.10.013.CrossRefPubMed
8.
go back to reference Détaint D, Faivre L, Collod-Beroud G, Child AH, Loeys BL, Binquet C, Gautier E, Arbustini E, Mayer K, Arslan-Kirchner M, Stheneur C, Halliday D, Beroud C, Bonithon-Kopp C, Claustres M, Plauchu H, Robinson PN, Kiotsekoglou A, De Backer J, Adés L, Francke U, De Paepe A, Boileau C, Jondeau G: Cardiovascular manifestations in men and women carrying a FBN1 mutation. Eur Heart J. 2010, 31 (18): 2223-2229. 10.1093/eurheartj/ehq258.CrossRefPubMed Détaint D, Faivre L, Collod-Beroud G, Child AH, Loeys BL, Binquet C, Gautier E, Arbustini E, Mayer K, Arslan-Kirchner M, Stheneur C, Halliday D, Beroud C, Bonithon-Kopp C, Claustres M, Plauchu H, Robinson PN, Kiotsekoglou A, De Backer J, Adés L, Francke U, De Paepe A, Boileau C, Jondeau G: Cardiovascular manifestations in men and women carrying a FBN1 mutation. Eur Heart J. 2010, 31 (18): 2223-2229. 10.1093/eurheartj/ehq258.CrossRefPubMed
9.
go back to reference Song HK, Kindem M, Bavaria JE, Dietz HC, Milewicz DM, Devereux RB, Eagle KA, Maslen CL, Kroner BL, Pyeritz RE, Holmes KW, Weinsaft JW, Menasche W, Rayekes W, Lemaire SA: Long-term implications of emergency versus elective proximal aortic surgery in patients with Marfan syndrome in the genetically triggered thoracic aortic aneurysms and cardiovascular conditions consortium registry. J Thorac Cardiovasc Surg. 2012, 143 (2): 282-286. 10.1016/j.jtcvs.2011.10.024.CrossRefPubMed Song HK, Kindem M, Bavaria JE, Dietz HC, Milewicz DM, Devereux RB, Eagle KA, Maslen CL, Kroner BL, Pyeritz RE, Holmes KW, Weinsaft JW, Menasche W, Rayekes W, Lemaire SA: Long-term implications of emergency versus elective proximal aortic surgery in patients with Marfan syndrome in the genetically triggered thoracic aortic aneurysms and cardiovascular conditions consortium registry. J Thorac Cardiovasc Surg. 2012, 143 (2): 282-286. 10.1016/j.jtcvs.2011.10.024.CrossRefPubMed
10.
go back to reference Zehr KJ, Orszulak TA, Mullany CJ, Matloobi A, Daly RC, Dearani JA, Sundt TM, Puga FJ, Danielson GK, Schaff HV: Surgery for aneurysms of the aortic root: a 30-year experience. Circ. 2004, 110 (11): 1364-1371. 10.1161/01.CIR.0000141593.05085.87.CrossRef Zehr KJ, Orszulak TA, Mullany CJ, Matloobi A, Daly RC, Dearani JA, Sundt TM, Puga FJ, Danielson GK, Schaff HV: Surgery for aneurysms of the aortic root: a 30-year experience. Circ. 2004, 110 (11): 1364-1371. 10.1161/01.CIR.0000141593.05085.87.CrossRef
11.
go back to reference Geisbuesch S, Schray D, Bischoff MS, Lin HM, Di Luozzo G, Griepp RB: Frequency of reoperations in patients with Marfan syndrome. Ann Thorac Surg. 2012, 93 (5): 1496-1501. 10.1016/j.athoracsur.2011.12.068.CrossRefPubMed Geisbuesch S, Schray D, Bischoff MS, Lin HM, Di Luozzo G, Griepp RB: Frequency of reoperations in patients with Marfan syndrome. Ann Thorac Surg. 2012, 93 (5): 1496-1501. 10.1016/j.athoracsur.2011.12.068.CrossRefPubMed
12.
go back to reference Radu NC, Kirsch EW, Hillion ML, Lagneau F, Drouet L, Loisance D: Embolic and bleeding events after modified Bentall procedure in selected patients. Heart. 2007, 93 (1): 107-112. 10.1136/hrt.2005.086009.CrossRefPubMed Radu NC, Kirsch EW, Hillion ML, Lagneau F, Drouet L, Loisance D: Embolic and bleeding events after modified Bentall procedure in selected patients. Heart. 2007, 93 (1): 107-112. 10.1136/hrt.2005.086009.CrossRefPubMed
13.
go back to reference Meijboom LJ, Timmermans J, Zwinderman AH, Engelfriet PM, Mulder BJ: Aortic root growth in men and women with the Marfan’s syndrome. Am J Cardiol. 2005, 96 (10): 1441-1444. 10.1016/j.amjcard.2005.06.094.CrossRefPubMed Meijboom LJ, Timmermans J, Zwinderman AH, Engelfriet PM, Mulder BJ: Aortic root growth in men and women with the Marfan’s syndrome. Am J Cardiol. 2005, 96 (10): 1441-1444. 10.1016/j.amjcard.2005.06.094.CrossRefPubMed
14.
go back to reference De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE: Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996, 62 (4): 417-426. 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R.CrossRefPubMed De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE: Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996, 62 (4): 417-426. 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R.CrossRefPubMed
15.
go back to reference Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewich DM, Pyeritz RE, Sponseller PD, Wordsworth P, De Paepe AM: The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010, 47 (7): 476-485. 10.1136/jmg.2009.072785.CrossRefPubMed Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewich DM, Pyeritz RE, Sponseller PD, Wordsworth P, De Paepe AM: The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010, 47 (7): 476-485. 10.1136/jmg.2009.072785.CrossRefPubMed
16.
go back to reference Gott VL, Pyeritz RE, Cameron DE, Greene PS, McKusick VA: Composite graft repair of Marfan aneurysm of the ascending aorta: results in 100 patients. Ann Thorac Surg. 1991, 52 (1): 38-44. 10.1016/0003-4975(91)91414-Q.CrossRefPubMed Gott VL, Pyeritz RE, Cameron DE, Greene PS, McKusick VA: Composite graft repair of Marfan aneurysm of the ascending aorta: results in 100 patients. Ann Thorac Surg. 1991, 52 (1): 38-44. 10.1016/0003-4975(91)91414-Q.CrossRefPubMed
17.
go back to reference Gott VL, Greene PS, Alejo DE, Cameron DE, Naftel DC, Miller DC, Gillinov AM, Laschinger JC, Pyeritz RE: Replacement of the aortic root in patients with Marfan’s syndrome. N Engl J Med. 1999, 340 (17): 1307-1313. 10.1056/NEJM199904293401702.CrossRefPubMed Gott VL, Greene PS, Alejo DE, Cameron DE, Naftel DC, Miller DC, Gillinov AM, Laschinger JC, Pyeritz RE: Replacement of the aortic root in patients with Marfan’s syndrome. N Engl J Med. 1999, 340 (17): 1307-1313. 10.1056/NEJM199904293401702.CrossRefPubMed
18.
go back to reference Pape LA, Tsai TT, Isselbacher EM, Oh JK, O’gara PT, Evangelista A, Fattori R, Meinhardt G, Trimarchi S, Bossone E, Suzuki T, Cooper JV, Froehlich JB, Nienaber CA, Eagle KA: Aortic diameter > or = 5.5 cm is not a good predictor of type A aortic dissection: observations from the International Registry of Acute Aortic Dissection (IRAD). Circ. 2007, 116 (10): 1120-1127. 10.1161/CIRCULATIONAHA.107.702720.CrossRef Pape LA, Tsai TT, Isselbacher EM, Oh JK, O’gara PT, Evangelista A, Fattori R, Meinhardt G, Trimarchi S, Bossone E, Suzuki T, Cooper JV, Froehlich JB, Nienaber CA, Eagle KA: Aortic diameter > or = 5.5 cm is not a good predictor of type A aortic dissection: observations from the International Registry of Acute Aortic Dissection (IRAD). Circ. 2007, 116 (10): 1120-1127. 10.1161/CIRCULATIONAHA.107.702720.CrossRef
19.
go back to reference Kim SY, Martin N, Hsia EC, Pyeritz RE, Albert DA: Management of aortic disease in Marfan Syndrome: a decision analysis. Arch Intern Med. 2005, 165 (7): 749-755. 10.1001/archinte.165.7.749.CrossRefPubMed Kim SY, Martin N, Hsia EC, Pyeritz RE, Albert DA: Management of aortic disease in Marfan Syndrome: a decision analysis. Arch Intern Med. 2005, 165 (7): 749-755. 10.1001/archinte.165.7.749.CrossRefPubMed
20.
go back to reference Aalberts JJ, Waterbolk TW, van Tintelen JP, Hillege HL, Boonstra PW, van den Berg MP: Prophylactic aortic root surgery in patients with Marfan syndrome: 10 years’ experience with a protocol based on body surface area. Eur J Cardiothorac Surg. 2008, 34 (3): 589-594. 10.1016/j.ejcts.2008.04.035.CrossRefPubMed Aalberts JJ, Waterbolk TW, van Tintelen JP, Hillege HL, Boonstra PW, van den Berg MP: Prophylactic aortic root surgery in patients with Marfan syndrome: 10 years’ experience with a protocol based on body surface area. Eur J Cardiothorac Surg. 2008, 34 (3): 589-594. 10.1016/j.ejcts.2008.04.035.CrossRefPubMed
21.
go back to reference Milewicz DM, Dietz HC, Miller DC: Treatment of aortic disease in patients with Marfan syndrome. Circ. 2005, 111 (11): e150-e157. 10.1161/01.CIR.0000155243.70456.F4.CrossRef Milewicz DM, Dietz HC, Miller DC: Treatment of aortic disease in patients with Marfan syndrome. Circ. 2005, 111 (11): e150-e157. 10.1161/01.CIR.0000155243.70456.F4.CrossRef
22.
go back to reference Matt P, Schoenhoff F, Habashi J, Holm T, Van Erp C, Loch D, Carlson OD, Griswold BF, Fu Q, De Backer J, Loeys B, Huso DL, McDonell NB, Van Eyk JE, Dietz HC: Circulating transforming growth factor-beta in Marfan syndrome. Circ. 2009, 120 (6): 526-532. 10.1161/CIRCULATIONAHA.108.841981.CrossRef Matt P, Schoenhoff F, Habashi J, Holm T, Van Erp C, Loch D, Carlson OD, Griswold BF, Fu Q, De Backer J, Loeys B, Huso DL, McDonell NB, Van Eyk JE, Dietz HC: Circulating transforming growth factor-beta in Marfan syndrome. Circ. 2009, 120 (6): 526-532. 10.1161/CIRCULATIONAHA.108.841981.CrossRef
23.
go back to reference Maeda S, Dean DD, Gay I, Schwartz Z, Boyan BD: Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles. J Bone Miner Res. 2001, 16 (7): 1281-1290. 10.1359/jbmr.2001.16.7.1281.CrossRefPubMed Maeda S, Dean DD, Gay I, Schwartz Z, Boyan BD: Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles. J Bone Miner Res. 2001, 16 (7): 1281-1290. 10.1359/jbmr.2001.16.7.1281.CrossRefPubMed
24.
go back to reference Gilmore SJ, Vaughan BL, Madzvamuse A, Maini PK: A mechanochemical model of striae distensae. Math Biosci. 2012, 240 (2): 141-147. 10.1016/j.mbs.2012.06.007.CrossRefPubMed Gilmore SJ, Vaughan BL, Madzvamuse A, Maini PK: A mechanochemical model of striae distensae. Math Biosci. 2012, 240 (2): 141-147. 10.1016/j.mbs.2012.06.007.CrossRefPubMed
25.
go back to reference Bruno L, Tredici S, Mangiavacchi M, Colombo V, Mazzotta GF, Sirtori CR: Cardiac, skeletal, and ocular abnormalities in patients with Marfan’s syndrome and in their relatives. Comparison with the cardiac abnormalities in patients with kyphoscoliosis. Br Heart J. 1984, 51 (2): 220-230. 10.1136/hrt.51.2.220.CrossRefPubMedPubMedCentral Bruno L, Tredici S, Mangiavacchi M, Colombo V, Mazzotta GF, Sirtori CR: Cardiac, skeletal, and ocular abnormalities in patients with Marfan’s syndrome and in their relatives. Comparison with the cardiac abnormalities in patients with kyphoscoliosis. Br Heart J. 1984, 51 (2): 220-230. 10.1136/hrt.51.2.220.CrossRefPubMedPubMedCentral
Metadata
Title
Possible extracardiac predictors of aortic dissection in Marfan syndrome
Authors
Bence Ágg
Kálmán Benke
Bálint Szilveszter
Miklós Pólos
László Daróczi
Balázs Odler
Zsolt B Nagy
Ferenc Tarr
Béla Merkely
Zoltán Szabolcs
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2014
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-14-47

Other articles of this Issue 1/2014

BMC Cardiovascular Disorders 1/2014 Go to the issue